AU731049B2 - Highly efficient controlled expression of exogenous genes in e. coli - Google Patents

Highly efficient controlled expression of exogenous genes in e. coli Download PDF

Info

Publication number
AU731049B2
AU731049B2 AU25642/99A AU2564299A AU731049B2 AU 731049 B2 AU731049 B2 AU 731049B2 AU 25642/99 A AU25642/99 A AU 25642/99A AU 2564299 A AU2564299 A AU 2564299A AU 731049 B2 AU731049 B2 AU 731049B2
Authority
AU
Australia
Prior art keywords
gene
promoter
heterologous gene
sequence encoding
dna sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU25642/99A
Other languages
English (en)
Other versions
AU2564299A (en
Inventor
William C. Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26753754&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU731049(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AU2564299A publication Critical patent/AU2564299A/en
Application granted granted Critical
Publication of AU731049B2 publication Critical patent/AU731049B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/18011—Details ssRNA Bacteriophages positive-sense
    • C12N2795/18111—Leviviridae
    • C12N2795/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU25642/99A 1998-01-28 1999-01-27 Highly efficient controlled expression of exogenous genes in e. coli Expired AU731049B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US7279498P 1998-01-28 1998-01-28
US60/072794 1998-01-28
US09/237,712 US6180391B1 (en) 1998-01-28 1999-01-26 Highly efficient controlled expression of exogenous genes in e. coli
US09/237712 1999-01-26
PCT/US1999/001725 WO1999038985A2 (en) 1998-01-28 1999-01-27 HIGHLY EFFICIENT CONTROLLED EXPRESSION OF EXOGENOUS GENES IN $i(E. COLI)

Publications (2)

Publication Number Publication Date
AU2564299A AU2564299A (en) 1999-08-16
AU731049B2 true AU731049B2 (en) 2001-03-22

Family

ID=26753754

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25642/99A Expired AU731049B2 (en) 1998-01-28 1999-01-27 Highly efficient controlled expression of exogenous genes in e. coli

Country Status (12)

Country Link
US (1) US6180391B1 (es)
EP (1) EP1051502B1 (es)
JP (1) JP4346819B2 (es)
AT (1) ATE345391T1 (es)
AU (1) AU731049B2 (es)
CA (1) CA2318813C (es)
DE (1) DE69933990T2 (es)
DK (1) DK1051502T3 (es)
ES (1) ES2275335T3 (es)
HK (1) HK1030965A1 (es)
PT (1) PT1051502E (es)
WO (1) WO1999038985A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6423544B1 (en) * 1998-12-31 2002-07-23 Chiron Corporation Compositions and methods for producing recombinant virions
WO2002088325A2 (en) 2001-05-02 2002-11-07 University Of South Florida Vector system for selection of genes encoding secreted proteins and membrane-bound proteins
USRE46351E1 (en) 2001-05-10 2017-03-28 Battelle Energy Alliance, Llc Antibody profiling sensitivity through increased reporter antibody layering
US7695919B2 (en) 2001-05-10 2010-04-13 Battelle Energy Alliance, Llc Antibody profiling sensitivity through increased reporter antibody layering
USRE44031E1 (en) 2001-05-10 2013-02-26 Battelle Energy Alliance, Llc Antibody profiling sensitivity through increased reporter antibody layering
US6989276B2 (en) 2001-05-10 2006-01-24 Battelle Energy Alliance, Llc Rapid classification of biological components
WO2005058946A2 (en) * 2003-12-12 2005-06-30 Zymogenetics, Inc. Methods for enhancing expression of recombinant proteins
WO2006091483A1 (en) * 2005-02-22 2006-08-31 David Tabaczynski Phage-derived vectors and methods for protein expression
ES2388548T3 (es) * 2005-04-08 2012-10-16 Bayer Cropscience Nv Suceso de élite A2704-12 y métodos y estuches para identificar a dicho suceso en muestras biológicas
US20080300796A1 (en) 2007-05-31 2008-12-04 Lassahn Gordon D Biological analysis methods, biological analysis devices, and articles of manufacture
WO2009021191A2 (en) * 2007-08-08 2009-02-12 Barnes Wayne M Improved t7 expression system
EP2445924B2 (en) 2009-06-25 2023-12-13 Amgen Inc. Capture purification processes for proteins expressed in a non-mammalian system
US9410965B2 (en) 2009-09-17 2016-08-09 Battelle Energy Alliance, Llc Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual
US8969009B2 (en) 2009-09-17 2015-03-03 Vicki S. Thompson Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual
CN115747187B (zh) * 2022-12-09 2023-06-20 厦门康基生物科技有限公司 一种重组酶UvsX及其表达基因和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503142A (en) 1982-06-25 1985-03-05 Litton Bionetics, Inc. Open reading frame vectors
US4578355A (en) 1983-01-12 1986-03-25 The United States Of America As Represented By The Department Of Health And Human Services Plasmid cloning vector pAS1
US4767708A (en) 1984-08-07 1988-08-30 Carnegie Mellon University Enzyme amplification and purification
WO1997004110A1 (en) 1995-07-14 1997-02-06 Somatogen, Inc. Methods for increasing protein expression

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
OUHAMMOUCH ET AL. 1995. PNAS 92:1451-1455 *
PEABODY 1990. J OF BIO CHEM 265(10):5684-5689 *
PEABODY 1993 EMBO J 12(2):595-600 *

Also Published As

Publication number Publication date
HK1030965A1 (en) 2001-05-25
US6180391B1 (en) 2001-01-30
CA2318813A1 (en) 1999-08-05
JP2002501752A (ja) 2002-01-22
WO1999038985A3 (en) 1999-11-18
WO1999038985A2 (en) 1999-08-05
EP1051502A2 (en) 2000-11-15
CA2318813C (en) 2006-06-06
DE69933990D1 (de) 2006-12-28
DE69933990T2 (de) 2007-09-20
EP1051502B1 (en) 2006-11-15
JP4346819B2 (ja) 2009-10-21
PT1051502E (pt) 2007-01-31
DK1051502T3 (da) 2007-02-26
AU2564299A (en) 1999-08-16
ES2275335T3 (es) 2007-06-01
ATE345391T1 (de) 2006-12-15

Similar Documents

Publication Publication Date Title
Neidhardt et al. The genetics and regulation of heat-shock proteins
AU731049B2 (en) Highly efficient controlled expression of exogenous genes in e. coli
KR100761486B1 (ko) 파아지를 이용한 생리 활성 단백질 및 펩티드의 대량생산법
AU2001284914A1 (en) Phage-dependent Superproduction of Biologically Active Protein and Peptides
JP4249832B2 (ja) トリガーファクター発現プラスミド
US20130203113A1 (en) METHOD OF STABILIZING mRNA
Ishiai et al. Mini-F plasmid mutants able to replicate in Escherichia coli deficient in the DnaJ heat shock protein
AU653922B2 (en) Enhancement of cell growth by expression of a cloned hemoglobin gene
Mullaney et al. Capsid targeting sequence targets foreign proteins into bacteriophage T4 and permits proteolytic processing
JPH04500754A (ja) 異種遺伝子発現のための改良細菌株
Obuchowski et al. An RNA polymerase α subunit mutant impairs N‐dependent transcriptional antiterminationin Escherichia coli
Hilliker et al. The activity of Salmonella phage P22 gene 24 product in Escherichia coli
KR100374672B1 (ko) 플라스미드
JP2545377B2 (ja) Ｄｎａ配列体
Baliko et al. An Escherichia coli gene in search of a function: phenotypic effects of the gene recently identified as murI
US20060172388A1 (en) Methods for enhancing expression of recombinant proteins
US5843703A (en) Enhanced production of toxic polypeptides in prokaryotes
US20090075270A1 (en) Products and Methods Relating to the Use of the Endoribonuclease Kid/PemK
Maiti et al. Bacteriophage λ P gene shows host killing which is not dependent on λ DNA replication
Slavcev et al. Identification and characterization of a novel allele of Escherichia coli dnaB helicase that compromises the stability of plasmid P1
Zou et al. A nested set of C‐terminal deletions of the α subunit of Escherichia coli RNA polymerase define regions concerned with assembly, proteolysis, stabilization and transcriptional activation in vivo
Taher Divergent effects on Escherichia coli chaperonin function by mutations in the GroES mobile loop
Matsutani The internal sequence of IS 1 stimulates RNA synthesis from the IS 1 own and exogenous promoters
Wycuff Examination of the C-terminal assembly motif in lactose repressor
Sullivan Transcriptional analysis of cell division genes in Escherichia coli

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired